| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000016748 |
| Receipt No. | R000019437 |
| Official scientific title of the study | A prospective cohort study regarding the correlation between gastrointestinal cancer and life-style related diseases |
| Date of disclosure of the study information | 2015/04/01 |
| Last modified on | 2017/05/31 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | A prospective cohort study regarding the correlation between gastrointestinal cancer and life-style related diseases | |
| Title of the study (Brief title) | A study regarding the correlation between gastrointestinal cancer and life-style related diseases | |
| Region |
|
|
| Condition | ||
| Condition | Esophageal cancer, Gastric cancer, Liver cancer, Colorectal cancer, Pancreatic cancer, Biliary cancer, disease in GI tract | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the relationship between gastrointestinal disease (including cancer) and life-style related diseases |
| Basic objectives2 | Others |
| Basic objectives -Others | observational study |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Detection rate (prevalence) of gastrointestinal disease (including cancer) in patients with life-style related diseases |
| Key secondary outcomes | Correlation between gastrointestinal disease (including cancer) and medications for life-style related diseases |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The subject who agreed to the purpose of this study in the patients visiting to Gifu University Hopsital, Gihoku Kosei Hospital and Nishimino Kosei Hospital. | |||
| Key exclusion criteria | The subject who did not agree to the purpose of this study in the patients visiting to Gifu University Hopsital, Gihoku Kosei Hospital and Nishimino Kosei Hospital. | |||
| Target sample size | 4000 | |||
| Research contact person | |
| Name of lead principal investigator | Seiji Adachi |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Gastroenterology |
| Address | 1-1 Yanagido, Gifu, Japan |
| TEL | 058-230-6308 |
| sadachi-gif@umin.ac.jp | |
| Public contact | |
| Name of contact person | Seiji Adachi |
| Organization | Gifu University Graduate School of Medicine |
| Division name | Gastroenterology |
| Address | 1-1 Yanagido, Gifu, Japan |
| TEL | 058-230-6308 |
| Homepage URL | |
| sadachi-gif@umin.ac.jp | |
| Sponsor | |
| Institute | Gifu University Graduate School of Medicine, Gastroenterology
|
| Institute | |
| Department | |
| Funding Source | |
| Organization | Gifu University Graduate School of Medicine, Regional Cancer Control
|
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 岐阜大学病院、岐北厚生病院、西美濃厚生病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | We are planning to elicidate
1) whether anti-platelet agents increases the detection rate of colorectal cancer by fecal occult blood test, since they cause bleeding tendency. 2) whether anti-diabetes mellitus agents reduce the prevalence of gastrointestinal cancers, since they can improve the resistance to insulin. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019437 |